Zurueck zur Suche

Reporte zur Charge UT7744NA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 2 FL 2 GA 1 TX 1 TN 1 MO 1 KY 1

VAERS 2628376

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

moderat
Staat
GA
Alter
1,0
Geschlecht
M
Eingang
08.05.2023
Impfdatum
03.01.2023
Beginn
05.01.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cough Dyspnoea Ear infection Nasopharyngitis Pyrexia Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

On 1/17/23, he had a common cold with an ear infection. He had congestion, fever, coughing, and difficulty breathing. We contacted his doctor and was prescribed Albuterol and Amoxicillin. We had to take him back to the doctor because he wasn't getting better, and they prescribed Cefdinir. This lasted until 2/6/23.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
19JANCOVID-19 Test - Negative; 16MAR2023 COVID-19 Test - Negative
Aktuelle Erkrankungen
Common Cold
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Cow's Milk Protein
Vorherige Impfungen
-

VAERS 2525639

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UT7744NA

moderat
Staat
FL
Alter
58,0
Geschlecht
F
Eingang
23.12.2022
Impfdatum
14.11.2022
Beginn
14.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Hypoaesthesia Magnetic resonance imaging Mobility decreased Musculoskeletal pain Immediate post-injection reaction Injection site hypoaesthesia Injection site pain Injection site swelling Injected limb mobility decreased Joint range of motion decreased Loss of personal independence in daily activities Muscle tightness Neck pain Pain Pain in extremity

Symptomtext

Immediate pain felt upon injection where I exclaimed to the Nurse that it hurt very much. Few hours later severe pain at injection site and severe swollen-ness. Pain and numbness has continued from top of shoulder (rotary cup) down to the left elbow. The area is hurts when touched (to-date from 11/14). Range of motion is limiting and painful when trying to raise arm up overhead especially while dressing. Arm is numb when first waking up. Upper arm hurts after long days at work from typing on computer. Today, Dec 7th - Pain now has moved to upper shoulder near left neck area and below slightly above the shoulder blade and is tight and painful to touch. I spoke to my Doctor on Monday, 12/5 and He advised to take ibuf I spoke with my Doctor on Monday, 12/5 and he advised I should take Ibuprofen up to 800 mg for the pain. I have a follow up Doctor Appointment (first available) on Thursday, Dec 15th.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Nothing to report (to-date)
Aktuelle Erkrankungen
NO
Vorgeschichte
N/A
Andere Medikamente
Fenofibrate 134 mg and Alendronate 70mg
Allergien
NO
Vorherige Impfungen
-

VAERS 2486465

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7744na

moderat
Staat
TX
Alter
60,0
Geschlecht
F
Eingang
23.10.2022
Impfdatum
30.09.2022
Beginn
30.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Mobility decreased

Symptomtext

Site: Pain at Injection Site-Medium, Additional Details: Patient has difficulty lifting are past chest level. Suggest ice and heat andapplication of diclofenac gel

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500263

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7744na

mild
Staat
TN
Alter
4,0
Geschlecht
M
Eingang
07.11.2022
Impfdatum
02.11.2022
Beginn
02.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Injection site erythema Injection site pain Scratch

Symptomtext

Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Additional Details: Patient jerked body away as I was administering vaccine I scratched him and told the mom and showed her. She sat in front of the pharmacy and I checked his temperature she said he was feeling light headed, after I gave him a lolipop he seemed much better and the dad and mom said it was due to seeing blood and he is completely fine. I called in about an hour and spoke to the mom and she said he is doing great.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2496582

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

mild
Staat
MO
Alter
38,0
Geschlecht
F
Eingang
02.11.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Oropharyngeal pain Swollen tongue

Symptomtext

APPROXIMATELY 1.5 HOURS AFTER RECEIVING HER FLU VACCINATION, SHE BEGAN TO FEEL HER TONGUE WAS SWOLLEN AND THROAT WAS SORE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None known.
Vorgeschichte
Asthma and allergies since covid diagnosis in Jan 2022.
Andere Medikamente
Unknown
Allergien
Stated she now has many allergies since she was diagnosed with Covid Jan. 2022 and sees an allergist now. Stated she is allergic to chicken but eats eggs without problem.
Vorherige Impfungen
-

VAERS 2486475

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

mild
Staat
FL
Alter
28,0
Geschlecht
M
Eingang
23.10.2022
Impfdatum
16.10.2022
Beginn
17.10.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Eye swelling Injection site erythema Injection site pruritus Injection site swelling Mouth swelling Peripheral swelling Pruritus Rash Swelling face Swollen tongue Urticaria

Symptomtext

Site: Itching at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Itch Generalized-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Additional Details: Patient said on 10/17 he had itching and hives that began in the axillary region of injected arm that eventually spread down and across his entire body. He said he experienced swelling of hands and hives all over trunk of body and into the inguinal area which prompted him to seek care at an urgent care. Within the next day it was flaring up again and he went to the emergency room on 10/19/22. He received additional care and the hospital doctors advised him to call us.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2524220

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

gering
Staat
KY
Alter
57,0
Geschlecht
M
Eingang
06.12.2022
Impfdatum
03.12.2022
Beginn
03.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

No adverse reaction

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2520595

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

gering
Staat
-
Alter
0,8
Geschlecht
M
Eingang
01.12.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Medication error No adverse event

Symptomtext

received 2nd shot of influenza before the correct time with no reported adverse event; Initial information was received on 28-Nov-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves 9 months old male patient who received 2nd shot of influenza quadrival a-b vaccine [Fluzone QIV] before the correct time with no reported adverse event. The patient had no medical history, concomitant disease or risk factor. On 03-Nov-2022, the patient received a total dose of suspect influenza quadrival a-b vaccine suspension for injection (lot UT7744NA) via intramuscular route in unknown administration site for influenza before the correct time with no reported adverse event (inappropriate schedule of product administration) (latency- same day). The patient did not experience any side effects or symptoms per his mother. There were no lab data/results available. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2509261

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UT7744NA

gering
Staat
NC
Alter
0,8
Geschlecht
U
Eingang
16.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Medication error

Symptomtext

they received a second dose instead of waiting for 30 days or more with no reported adverse event; Initial information received on 03-Nov-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 9 months old patient of unknown gender who received a second dose of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] instead of waiting for 30 days or more with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose 2 of suspect of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE (Suspension for injection) (lot: UT7744NA ) (expiry date: 30-JUN-2023) (strength was unknown) via unknown route in unknown administration site as prophylactic vaccination. On an unknown date the patient received a second dose of INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] instead of waiting for 30 days or more with no reported adverse event (inappropriate schedule of product administration) (unknown latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506922

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744NA

gering
Staat
NC
Alter
0,7
Geschlecht
M
Eingang
14.11.2022
Impfdatum
18.10.2022
Beginn
03.11.2022
Tage bis Beginn
16,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

received his second FLUZONE QUADRIVALENT vaccine only 3 weeks after the first with no reported adverse event; Initial information received on 04-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 months old male patient who received his second fluzone quadrivalent vaccine only 3 weeks after the first with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 VACCINE (COVID-19 VACCINE) for Immunisation. On 18-Oct-2022, the patient received 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (formulation, strength and lot number not reported) via unknown route in unknown administration site for prophylactic immunization. On 03-Nov-2022, he also received 0.5 mL dose of the same vaccine (lot UT7744NA) via intramuscular route in the left vastus lateralis for prophylactic vaccination. On 03-Nov-2022, (latency: same day) the patient received his second fluzone quadrivalent vaccine only 3 weeks after the first with no reported adverse event (inappropriate schedule of product administration) 16 days following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
COVID-19 VACCINE
Allergien
-
Vorherige Impfungen
-